C. Cooper

Cohort Profile: The Canadian HIV-Hepatitis C Co-infection Cohort Study

Marina B. Klein, Sahar Saeed, Hong Yang et al. · International Journal of Epidemiology · 2009 · 93 citations · Full text

Hepatitis C Virus, Immunology, Hepatitis B +17

1359 FIRST SVR DATA WITH THE NUCLEOSIDE ANALOGUE POLYMERASE INHIBITOR MERICITABINE (RG7128) COMBINED WITH PEGINTERFERON/RIBAVIRIN IN TREATMENT-NAIVE HCV G1/4 PATIENTS: INTERIM ANALYSIS FROM THE JUMP-C TRIAL

Paul J. Pockros, Dorte Møller Jensen, N. Tsai et al. · Journal of Hepatology · 2011 · 45 citations

Interim Analysis, The Jump-c Trial, Viral Hepatitis +6

Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3

Jeff Powis, Kevork Peltekian, Shoei‐Sheng Lee et al. · Journal of Viral Hepatitis · 2007 · 36 citations · Full text

50 BOCEPREVIR PLUS PEGINTERFERON/RIBAVIRIN FOR THE TREATMENT OF HCV/HIV CO-INFECTED PATIENTS: END OF TREATMENT (WEEK 48) INTERIM RESULTS

Josep Mallolas, Stanislas Pol, Antonio Rivero et al. · Journal of Hepatology · 2012 · 27 citations

Viral Hepatitis, Week 48, Antiviral Drug Development +10

Factors Associated With Discordance Between Absolute CD4 Cell Count and CD4 Cell Percentage in Patients Coinfected With HIV and Hepatitis C Virus

Mark Hull, K. Rollet, Adefowope Odueyungbo et al. · Clinical Infectious Diseases · 2012 · 26 citations · Full text